Title: Effect of Vitamin B12 on Renal function of albino rats infected with Trypanosoma brucei

Authors: Adebayo Olugbenga Adegoke, Ibitoroko Maureen George-Opuda, Nnamdi Isaac Nnatuanya, Marygolden Chika Umeh

 DOI: https://dx.doi.org/10.18535/jmscr/v9i8.09

Abstract

This study was carried out to determine the effect of vitamin B12 on the renal functions of male Wister albino rats infected with Trypanosoma brucei brucei. 24 male Wistar albino rats were divided into 6 groups of for rats each namely; control, Trypanosome infected, diamenazene treated, 40mcg vitaminB12, 60mcg vitamin B12, 80mcg vitamin B12. The renal indicators such as urea, creatinine, sodium, potassium and chloride were determined in all the albino rats using urease Berthelot for urea, modified Jaffe’s for creatinine while ion selective electrode analyzer was used for  sodium, potassium and chloride. The data was subjected to statistical analysis using statistical package for social sciences (SPSS) version 20. The result showed that there was a significant increase (P<0.05) in the mean value of serum urea (mmol/l), creatinine (mg/dl), sodium (mmol/l), potassium (mmol/l) and chloride (mmol/l) in trypanosome infected group (29.00±0.6, 4.00±0.35, 154.52±2.67, 20.74±13.59 and 129.23±0.23) respectively when compared to control (13.55±0.47, 1.25±0.65. 133.40±1.42, 2.15±0.02 and 101.18±1.43) respectively. The diamenazene treated showed a significant increase (P<0.05) in the mean value urea (mmol/l), sodium (mmol/l), potassium (mmo/l), chloride (mmol/l) and significant decrease in creatinine (md/dl) (19.28±0.23, 138.30±1.50, 4.04±0.11, 1.0292±0.93 and 1.00±0.13) respectively when compared to control (13.55±0.47,133.40±1.42, 2.15±0.02, 101.18±1.43 and 1.25±0.65) respectively. The vitamin B12 treated group showed a significant increase (P<0.05) in the mean value of serum urea (mmol/l), creatinine (mg/dl), sodium (mmol/l), potassium (mmol/l) and chloride (mmol/l) in all doses; 40mcg (22.28±0.72, 2.03±0.34, 149.60±1.38, 6.27±0.39 and 116.48±4.74), 60mcg (21.45±0.83, 2.10±0.14, 153.40±2.58, 5.77±0.26 and 119.28±7.80) and 80mcg (21.28±0.38, 2.50±0.27, 152.40±0.99, 6.22±0.39 and 111.95±2.94) respectively when compared to the control group (13.55±0.47, 1.25±0.65, 133.40±1.42,  2.15±0.02 and 101.18±1.43) respectively. The result of the study suggested that oral administration of vitamins B12 and E reduced the changes in renal dysfunction associated with Trypanosoma brucei brucei infection in Wistar albino rats.

Keywords: Vitamin B12, Renal function, Trypanosome.

References

  1. Kennedy, P.G.E. (2004). Human African Trypanosomiasis of the CNS: Current issues and challenges. Journal of Clinical investigation,113,496-504
  2. Kristjanson P.M., Swallow B.M., Rowland G.J., Krusoka R.L.,Belew P.P.(1999).Measuring the cost of animal African trypanosomiasis, the potential benefit of control and returns to research. Agr.Sys. 59(1) 79-98.
  3. Bourn D., Grant I, Shaw A., Torr S, (2005). Cheap and safe tsetse control for livestock production and mixed farming in Africa. Asp. Appl. Biol. 75
  4. Kioy D. and Mattock, N. (2005).Control of sleeping sickness time to integrate approaches. Lancet 366(9487)695-696
  5. Moore, AC (2005). Prospects for improving African trypanosomiasis-chemotheraphy. J. infectious Dis. 191 1793-1795
  6. Jannin J. and Cattand, P (2004). Treatment and control of human African trypanosomiasis. Current Opinion Infection Disease 17; 565-571
  7. Chibale K. (2005). Economic drug discovery and rational medicinal chemistry for tropical diseases. Pure Applied Chem. 77 1957-1964
  8. Pink R., Hudson A., Mouries M-A., Bendig M. (2005).Opportunities and anti parasitic drug discovery. National Review Drug Discover 49:727-740,
  9. WHO (World Health Organization) (2006). African trypanosomiasis (sleeping sickness) http://www.who.int/mediacentre/factsheet/fs259/ena.
  10. Herbert V, Das K.(1994) Vitamin B12 in Modern Nutrition in Health and Disease. 8th ed. Baltimore, MD: Williams & Wilkins, 63:12-24
  11. Combs G.( 1992) .Vitamin B12 in The Vitamins. New York: Academic Press, Inc.,
  12. Clarke R. B. (2008). Vitamins and prevention of dementia. Proc Nutrition Society, 67:75-81.
  13. Herbert W. J, and Lumsden W. H (1976) Trypanosoma brucei: a rapid “matching” method for estimating the hostsparasitemia. Exp. Parasitology,40 (3):427-31.
  14. Ion selective electrode series operator manual (2012). SFRI, Medical Diagnostics, 18-19.
  15. Weatherburn, M.W. (1967). Phenol-hypochlorite reaction for determination of ammonia. Analytical Chemistry, 39:971-974.
  16. Henry R.J.(1974). Creatinine in: Clinical Chemistry, principles and techniques.2nd edition, Harper and Row4:510-525.
  17. Ismaila AU, Zipporah AT, Funnilayo II, Abubakar G. Lawan BB (2000). The Role of Vitamin B12 and E Administration in Alleviation of kidney Damage in Rats Infected with Trypanosoma brucei. Journal of Clinical Biochemical. Nutrition.28: 1-7.
  18. Umar I.A, Rumah B.L, Asueliman B.I, Mazai M.H, Ibrahim M.A, Isah S. (2008): Effects of intraperitoneal administration of vitamins B12 and E combinations on the severity of Trypanosoma brucei brucei infection in rats. African Journal of Biochemical Research,2 (3): 088-091.
  19. Kaplan L.A, Szabo L.L, Opherin E.K. (1988). Renal markers in clinical chemistry: Interpretation and Techniques. 3rd eds. Lea and Febliger, Philadelphia.9:182 – 184.
  20. Anosa V.O, Kaneko J.J. (1984). Pathogenesis of T bruceiinfection in deer mice ( maniculatus). Ultra structural pathology of the spleen, liver, heart and kidney. Veterinare Pathology,21:229-237
  21. Bruijn J.A, Oemar B.S, Ehrick H.H, Foidart J.M., Flueures G.J. (1987). Antibasement membrane glomerulopathy in experimental trypanosomiasis. Journal of Immunology. 139:2482- 2485.
  22. Adamu, U. O., Orbagbedia R. P., Nwezor F.N.C. and Muhammed M. (2008). T. brucei infection of rabbits. Journal of Parasitology, 3:1-5
  23. Vanveilthuysen M.L., Bruijn J.A. and Vanleer E.H. (1992). Pathogenesis of trypanoaomiasis induced glomerulonephritis in mice. Nephrol Dial Transplant, 7:507-51
  24. Kahn C. M. (2005). Blood parasites. The Merck Veterinary Manual, Merck & Co. inc.

Corresponding Author

Dr Adebayo O.Adegoke

Department of Medical Laboratory Science, Madonna University, Elele, Nigeria